Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse  by Lajeunesse, Daniel et al.
Kidney International, Vol. 50 (1996), pp. 1531—1538
Direct demonstration of a humorally-mediated inhibition of renal
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Direct demonstration of a humorally-mediated inhibition of renal
phosphate transport in the Hyp mouse. The murine Hyp model repro-
duces the characteristics of human X-linked hypophosphatemia (XLH),
an inherited disease causing renal loss of phosphate (Pi), severe rickets
and osteomalacia. A current hypothesis considers that a humoral factor
may be responsible for the renal Pi loss, although in vitro experiments with
renal cell models have failed to demonstrate the presence of such a factor
in XLH or in the 1-lyp mouse model. To test this hypothesis directly, we
prepared primary mouse proximal tubule cell cultures (MPTC), express-
ing normal features of proximal tubule cells. These cells possess high
alkaline phosphatase activity, and respond to human parathyroid hormone
fragment 1-34 (PTH) with a four- to sixfold increase in cAMP production
but do not respond to either arginine vasopressin (AVP) or to salmon
calcitonin (sCT). They also show sodium-dependent phosphate, glucose
and amino acid uptake. The presence of 10% Hyp mouse serum in
HAMF12/DMEM media (1 miu Pi) for the last 48 hours of culture of
MPTC reduced Pi uptake (0.1 mrvt 32P-Pi in the presence of 140 ms NaCl)
by 45.7 3.9% (P < 0.01) as compared to normal mouse serum. This
effect of Hyp mouse serum was dose-dependent between 5 to 20% (final
concentration) in culture media for the last 48 hours of culture (P < 0.01
by analysis of variance). This effect of Hyp mouse serum was also
time-dependent, with a lag time of at least 12 hours. Indeed, no significant
inhibition of Pi uptake could be detected with incubations less than 12
hours in the presence of 10% Hyp mouse serum, whereas a maximal effect
was obtained after 24 hours of incubation and remained unchanged after
36 and 48 hours. The inhibition of phosphate uptake by Hyp mouse serum
was specific, since neither sodium-dependent glucose nor cs-aminobutyric
acid uptake was modified under these conditions. MPTC cells showed a
very nice adaptation to Pi concentration in the media; low Pi (0.4 m final
concentration in the presence of 10% serum) stimulated Pi uptake,
whereas high Pi concentration (3 mM) reduced Pi uptake by these cells as
compared to regular HAMF12/DMEM media containing 1 mM Pi.
Normal and Hyp mouse serum both inhibited Pi uptake by MPTC
following adaptation in low or normal Pi media, however, Hyp mouse
serum always showed a stronger inhibition than normal serum. In contrast,
adaptation of MPTC in high Pi media resulted in no inhibition of
phosphate uptake either in the presence of normal or Hyp mouse serum.
We next questioned whether conditioned media from confluent Hyp
mouse primary osteoblast-like cell cultures could affect Pi uptake by
MPTC. These osteoblast-like cells expressed high alkaline phosphatase
and produced the bone specific protein, osteocalcin. When MPTC were
treated for 48 hours with Hyp mouse hone cell media conditioned for the
last 48 hours of cultures, Pi uptake was specifically inhibited by 30.5
4.1% (P < 0.025) as compared to normal mouse bone cell-conditioned
media. This effect of primary 1-lyp mouse bone cell-conditioned media is
specific for these cells since it was not observed with CHO cell-conditioned
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media, nor with either mouse fibroblast (NCTC), normal mouse Kupifer
cell- or Hyp mouse Kupifer cell-conditioned media. This effect also
persisted through a number of passages of Hyp mouse bone cells, since
conditioned-media from cells at their third passage still resulted in a 32
9.4% inhibition (P < 0.02). These results are the first to show an effect of
Hyp mouse serum on Pi uptake by primary renal cell cultures in vitro. This
effect is dose- and time-dependent, requiring 24 hours for maximum
response, and is blocked in Pi rich media. These results also suggest that
a specific intrinsic cellular defect, present in Hyp mouse osteoblasts, is
responsible for the release of and/or the modification of a factor that can
reach the circulation and which inhibits renal phosphate reabsorption. The
molecular nature of this factor and its mode of action remains to be
determined.
In human X-linked hypophosphatemia (XLH), the renal phos-
phate waste is attributable to a specific reduction of Pi reabsorp-
tion in the proximal tubule [1], a situation also observed in the
murine homologue Hyp [2—5]. In the Hyp mouse, two distinct
sodium-phosphate (NaPi) cotransport systems are active in renal
brush border membrane vesicles prepared from proximal tubules
[61. The Hyp phenotype is specifically characterized by a reduction
by half of the high affinity-low capacity transporter system (NaPi2)
[6]. The gene coding for this high-affinity transporter has been
identified by expression cloning in human (NaPi3) and in rat
kidneys [7]. In human, NaPi3 is localized on chromosome 5q35 [8],
thus strongly arguing against the hypothesis that XLH is a defect
in the renal Na-Pi cotransporter.
When a parabiosis between a normal and a Hyp mouse is
performed, the normal mouse becomes progressively hypophos-
phatemic (about one week) in association with a diminished renal
reabsorption of phosphate [9]. Separation of the joined mice
rapidly restores plasma phosphate to normal in the genetically
normal mouse, thus arguing in favor of a humorally mediated
mechanism. This effect persisted even after parathyroidectomy,
which indicates that parathyroid hormone could not be the
humoral factor [101, a conclusion that was also reached by Cowgill
et al [11]. Kidney transplantation from normal to Hyp and from
[-lyp to normal mice failed to modify circulating Pi levels in
recipients, thus showing that the Hyp mouse phenotype was not
corrected nor transferred by renal transplantation [12]. It is also of
great interest that following kidney transplantation from his
normal sister, due to renal failure, an XLH patient continued to
have low plasma phosphate with low renal retention of phosphate
[13]. PEX, a gene with homologies to the neutral endopeptidase
family, has been proposed as a candidate gene for human XLH
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[14]. Other members of this family affect the activity of a variety
of peptide hormones [14]. These results suggest that the phos-
phate transport defect in Hyp mice, and likely human X-linked
hypophosphatemia, is the result of a humoral factor, and is not an
intrinsic renal abnormality [121.
Clinical and fundamental observations also suggest that an
intrinsic bone cell defect may be present. High Pi diet and
pharmacological doses of calcitriol improve phosphorus balance
[2, 15—18]. However, rickets never completely heal even in the
face of active mineralization [15, 16, 19], and short stature is never
fully restored even after years on this regime [1]. Bone cell
transplants from Hyp mice into normal recipients show reduction,
but not normalization, of the osteoid thickness and volume
(indices of abnormal mineralization) [20]. In contrast, abnormal
bone formation is observed when normal bone cells are trans-
planted into mutant mice, demonstrating a critical role of the Hyp
environment on osteogenesis [21].
A direct evidence for a humoral mediation of Pi uptake
inhibition by primary renal proximal tubule cells has never been
reported in XLH or in the Hyp mouse, whereas the presence of
such a factor has been proposed to explain hypophosphatemia in
cases of oncogenic osteomalacia using opossum kidney cells (OK
cells) as a model of proximal tubule cells [22, 231. These obser-
vations prompted us to use primary mouse proximal tubule cell
cultures to test this hypothesis directly in the Hyp mouse. We
evaluated the time- and dose-response of Hyp mouse serum, and
the adaptation to phosphorus loading of these primary renal cells.
We also investigated the origin of this factor by evaluating the
phosphate transport inhibitory potential of normal and Hyp
mouse bone cell-conditioned media on these primary renal cells.
Finally, the specificity of this factor was evaluated using condi-
tioned media from other primary mouse cells, and established cell
lines.
Methods
Animals
Male mice of the C57BL/6J strain, both normal (C57BL/6J
+/Y) and Hyp (C57BL/6J Hyp/Y) were obtained from our own
breeding colony. Hyp mice were identified by their shorter body
length, shorter tail length, lower weight and reduced serum
phosphorus levels (1.56 0.10 vs. 2.99 0.22 mrvi, P < 0.001).
After 24 hours of recuperation, the cells were treated with the
same media as above containing either 10% FBS (control), 10%
normal mouse serum or 10% Hyp mouse serum for 48 hours. In
other experiments, MPTC were treated for 48 hours either with
conditioned media from normal or Hyp mouse osteoblast-like cell
cultures (see below) or media incubated in the absence of cells.
MPTC were then used to measure Na-dependent Pi, glucose and
a-aminobutyric acid uptake separately. Lastly, the dose- and
time-dependent effect of Hyp mouse serum on Pi uptake were
tested. MPTC cells were incubated for the last 48 hours of culture
with 5 to 20% normal or Hyp mouse serum prior to Pi uptake
assays. For the time-dependent assays, MPTC were treated with
normal or Hyp mouse serum at a final concentration of 10% for
12, 24, 36 or 48 hours prior to uptake.
Phenozypic determination of primary mouse proximal tubule cell
cultures
Cyclic AMP formation in response to parathyroid hormone
(human PTH fragment 1-34, 100 nM), salmon calcitonin (sCT, 100
nM), arginine vasopressin (AVP, 100 nM), serum or conditioned
media was evaluated by RIA as previously described [26, 271.
Hormones were purchased from Peninsula (Belmont, CA, USA).
The alkaline phosphatase (ALPase) activity of MPTC was evalu-
ated by the hydrolysis of p-nitrophenyl phosphate as previously
described [21, 25].
Adaptation of mouse proximal tubule cell cultures to phosphate
loading in vitro
The capacity of MPTC to adapt to variable phosphate loads in
vitro was tested to: (a) verify that these cells can adapt to
phosphate loading by variations in Pi uptake; (b) determine how
this would affect their response to mouse serum. MPTC were first
prepared as described above and grown in regular HAMFI2/
DMEM media (in 24 well plates) for six days, until reaching
confluence. These cells were then separated into three groups
receiving the same media but containing low Pi (0.4 mM final Pi
concentration), normal (1 mM) and high Pi (3 mM). Final phos-
phate concentration in the media was adjusted in individual
experiments according to the phosphate concentration of tested
sera (FBS, normal or Hyp mouse) as evaluated within our clinical
facilities. Following two days of conditioning under these condi-
tions, Pi uptake by MPTC was performed as described below.
Mouse primary proximal tubule cell cultures (MPTC)
Proximal tubules were prepared by our modification [24] of the
original method of Vinay, Gougoux and Lemieux [25]. Collage-
nase digestion (1 mg/mi, Type V; Sigma, St. Louis, MO, USA) of
normal mouse kidney cortexes (3 mice per experiment) was done
followed by a separation on Percoll gradient. Proximal tubules
were recuperated, washed with Krebs-Henselcit buffer pH 7.4
containing 0.5% bovine serum albumin (KHBB), and the tubules
were put in culture in the presence of 45% HAMFI2 (Ham's
formula 12), 45% DMEM (Dulbecco's modified eagle media)
media (Sigma) containing 10% heat-inactivated fetal bovine se-
rum (FBS; Bio Whittaker, Walkersville, MD, USA) and 1%
penicillin-streptomycin (Pen-Strep; Gibco-BRL, Grand Island,
NY, USA). Cells attached overnight, and mouse primary proximal
tubule cells (MPTC) became confluent in six days. MPTC were
then split once, and put in 24 wells plates.
Mouse primary bone cell cultures
Long hones, obtained from posterior limbs of both normal and
[-lyp mice, were stripped of connective and muscular tissues. The
bones were cleaned of hone marrow with sterile phosphate
buffered saline, pH 7.4 (Gibco-BRL, Grand Island, NY, USA),
containing 6% Pen-Strep (PBSP) with a 27 G needle. Bones were
cut in small pieces, washed in PBSP and subjected to three
successive collagenase (Type I, I mg/mi) digestions of 20, 20 and
40 minutes, respectively [26]. The digested bone fragments were
put in HAMF12/DMEM media containing 10% FBS and 1%
Pen-Strep, and cell outgrowths appeared within seven days. At
confluence, hone cells were split once with 0.025% Trypsin and
0.05% EDTA (Sigma), plated at high density in 24 well plates and
treated as MPTC (see above). Conditioned-media (CM) was
prepared separately from normal and Hyp mouse hone cell
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cultures treated with 10% FBS for 48 hours. Osteocalcin secre-
tion, measured by RIA, and ALPase were determined on these
cells as previously described [26, 271. In a series of experiments,
bone cells (normal and Hyp) were kept in culture in 60 mm petri
dishes for two passages (split and seeded at 25,000 cells/cm2 at
each passage) before being split and distributed in 24 well plates
as indicated above (third passage). These cells were then treated
with HAMFI2/DMEM containing 10% FBS until reaching con-
fluence. Conditioned media was then prepared as above.
Selective effect of bone cell-conditioned media on Pi uptake
To evaluate the specific effect of bone cell-conditioned media
on renal cells, a variety of conditioned media from primary cells
and established cell lines were tested. Primary normal mouse and
Hyp mouse Kupifer-like cells were prepared following a modifi-
cation of the procedure of Janousek, Strmen and Gervais [28].
Briefly, denser Kupffer-like cells were separated on a 40% Percoll
gradient (see procedure for MPTC above) following a collagenase
digestion of 60 minutes. This procedure eliminates hepatocytes,
very sensitive to collagenase digestion, and separates endothelial
(light) and Kupifer cells (dense). Cells were plated at high density
in HAMF12/DMEM media containing 10% serum and 1% insu-
lin-transferrin-selenium mix (ITS; Sigma) for the first two days of
culture. This media was then changed for the same without ITS
every two days, and cell-conditioning was performed on the 6th
day of culture for the following 48 hours. Established mouse
fibroblasts (NCTC cells) and Chinese hamster ovary cells (CHO)
were provided by Dr. S. St-Jacques and Dr. E. Drobetsky,
respectively, from Maisonneuve-Rosemont Hospital. NCTC cells
were grown in HAMF12/DMEM media containing 10% FBS, and
CHO cells were grown initially in uMEM media containing 5%
FBS. For individual experiments, both cell lines were split and
plated at very high density in 24 well plates. After two days of
recovery, they were both fed with HAMF12/DMEM (1 mivi Pi)
containing 10% FBS for the following two days of conditioning.
These cell-conditioned media were then used on MPTC for 48
hours prior to Pi uptake experiments.
Phosphate, glucose and amino acid uptake
Transport experiments with MPTC were performed at 37°C in
the incubation buffer made of 140 mivi NaCl, 5 ms KC1, 1 mM
MgCl2 and 10 mrvi Hepes-Tris buffer pH 7.4, containing either 0.1
mM 32P-phosphate (NEN-DuPont, Mississauga, Ontario, Canada)
at 2 iCi/ml, 0.1 mivi 3H-glucose (NEN-DuPont) at 3 jiCi/mI or 0.1
mM 3H-a-aminobutyric acid (NEN-DuPont) at 2 pCi/mI. Na-
independent Pi uptake was assessed by measuring 32P-phosphate
uptake in the presence of 140 ifiM choline Cl (Sigma) to replace
NaCI. The uptake was terminated by removing the incubation
buffer and washing the cells three times with ice-cold incubation
buffer, without isotopes, containing 1 m sodium arsenate, 1 mM
phloridzin or 1 m cold alanine (all purchased from Sigma) to
inhibit Pi, glucose or amino acid uptake, respectively. Cells were
then covered with 500 1.d of a buffer made of 100 mM glycine, pH
10.5, 1 mM MgC12 and 1 mtvi ZnSO4 containing 0.1% Triton
X-100. This was agitated at 100 rpm on a shaking orbital platform
overnight at 4°C. Aliquots were counted, and protein content was
determined by the BCA method [291.
Fig. 1. Features of mouse primaly renal cells and production of cAMP in
response to mouse serum and bone cell-conditioned media. Primary mouse
proximal tubule cells (MPTC) were incubated for 10 minutes in the
presence of either human parathyroid hormone fragment 1-34 (PTH, 100
nM), arginine vasopressin (AVP, 100 nM), salmon calcitonin (sCT, 100
nM), 10% normal or Hyp mouse serum or conditioned-media from normal
or Hyp mouse bone cells. Values arc the mean SEM of 6 experiments.
< 0.005 versus control (CTL).
Statistical analysis
Two-tailed t-tests were performed for cAMP analysis, alkaline
phosphatase activity and osteocalcin determination. For the up-
take experiments, analysis of variance were performed, and a level
of 0.05 was considered to be significant. All data are reported as
mean SEM.
Results
MPTC cultures in vitro expressed characteristic features of
proximal tubule cells in vivo. MPTC showed cAMP formation in
response to parathyroid hormone (PTH), but not to salmon
calcitonin (sCT), nor to arginine vasopressin (AVP) (Fig. 1).
These cells possess high levels of alkaline phosphatase (108 15
nmol/mg protein/30 mm, N = 4), and Na-dependent Pi, glucose
and a-aminobutyric acid uptake (Figs. 2 and 3). Pi uptake in the
absence of extracellular Na was less than 10% of total uptake in
the presence of Na (Fig. 2), and the uptake was linear for the
first 10 minutes (not shown).
Hyp mouse serum (10%, 48 hr) inhibited Pi uptake by 45.7
3.9% (P < 0.01) as compared to normal mouse serum (Fig. 2;
63.3 8% as compared to control cells treated with FBS).
Normal mouse serum also inhibited this uptake as compared to
controls (36.3 11%, P < 0.05). This inhibition with serum is
specific for Na -Pi cotransport (P < 0.005 by analysis of variance
between the three groups) since it did not affect glucose nor
a-aminobutyric acid uptake (Fig. 3). Moreover, the effect of Hyp
mouse serum is dose-dependent. Although significant differences
were noted between normal mouse serum and controls at all
concentrations tested (P < 0.05), they were much less pronounced
than with Hyp mouse serum (Fig. 4). Statistical differences
*
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Fig. 2. Effect of Hyp mouse serum on Pt uptake by MPTC cultures.
Phosphate uptake (0.1 mvi 32P-KH2PO4) was measured in the presence of
140 mvi NaC1 (Plus Na) or 140 m choline chloride (No Na) for five
minutes at 37°C. Cells were pretreated for 48 hours with either 10% FBS
(Control), 10% normal mouse serum or 10% Hyp mouse serum prior to
uptake. Values are the mean SEM of 6 to 10 experiments run in triplicate
dishes per condition (P < 0.005 by analysis of variance between FBS,
normal and Hyp serum). *p < 0.005, *p < 0.05 versus FBS.
E
00.
0
E0.
Fig. 3. Glucose and a-aminohutyric acid uptakes by MPTC cultures. Solute
uptakes (0.1 m'vi final concentration) were measured at 37°C for five
minutes in the presence of 140 ms NaCI. Cells were preincubated with
10% FBS (Control, ), 10% normal mouse serum (•) or 10% Hyp mouse
serum () for48 hours prior to uptake. Values are the mean sivi of 3
or 4 experiments run in triplicate dishes per condition.
Fig. 4. Dose-response of normal ( and Hyp (t mouse serum on Pt
uptake by MPTC. Cells were incubated in the presence of 5 to 20% serum
for the last two days of culture prior to Pi uptake (0.1 mM) in the presence
of 140 mvi NaCI. Results for 0% mouse serum were obtained with cells
incubated in the presence of 10% FBS. Values are the mean SEM of
three experiments. (P < 0.005 by analysis of variance between the three
groups of concentrations tested for Hyp mouse serum). P < 0.05, **p <
0.025 between normal and Hyp mouse serum at the same final concentra-
tion.
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under the present conditions the concentration of PTITI in the
culture media would be in the M range, at least two orders of
magnitude below the doses inducing cAMP formation and Pi
uptake inhibition in vitro [31]. Indeed, preincubation for 48 hours
with the appropriate media containing either normal or Hyp
mouse serum, or conditioned-media from normal or Hyp mouse
bone cells, failed to elevate cAMP in MPTC (Fig. 1). Hyp mouse
serum inhibited phosphate uptake by MPTC only after long
exposures. No significant inhibition of phosphate uptake by
MPTC could be detected after 12 hours of incubation between
normal and Hyp mouse serum (Fig. 5). In contrast, phosphate
uptake was fully inhibited by Hyp mouse serum (vs. normal serum)
after 24 hours of incubation and remained unchanged thereafter
(36 and 48 hr). Moreover, a significant inhibition of Pi uptake by
MPTC (P < 0.05) with normal mouse serum treatments was also
noted after 36 and 48 hours of incubation.
MPTC adapted to Pi loading in vitro. When cells were kept in
low Pi media (0.4 m final) for two days, Pi uptake by MPTC was
increased by 50 to 60% as compared to cells grown in normal (1
mM) Pi media (Fig. 6). Moreover, Pi uptake by MPTC was
reduced following treatment in high Pi media for two days
(—25%). Variations in Pi loading of MPTC also resulted in an
adaptation of the response to mouse serum. Whereas both normal
and Hyp mouse serum inhibited Pi uptake by MPTC grown in the
presence of low or normal Pi media (inhibition with Hyp mouse
serum was always higher than with normal mouse serum), this
effect was totally lost upon treating cells with high Pi media (Fig.
6). It is also interesting to note that following high Pi loading, Pi
between normal and Hyp mouse serum were also noted at
concentrations of 10 (P < 0.05) and 20% (P < 0.025; Fig. 4).
Secondary hyperparathyroidism in Hyp mice [30] could not
explain the inhibiton of Pi uptake observed in our assays, since
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Fig. 5. Time-dependent effect of Hyp mouse serum on phosphate uptake by
MPTC. Cells were preincubated in the presence of 10% Hyp mouse serum
for 12, 24 36 or 48 hours prior to uptake experiments. Conditions of
phosphate uptake as described in Figure 2. Values are the mean SCM of
4 experiments. A significant difference was obtained after 24 hours of
incubation between normal and Hyp mouse serum (*P < 0.05), and was
maintained throughout the entire 48 hours of incubation. P < 0.005, "P <
0.05 versus control group (treatment time 0).
uptake by MPTC treated with normal serum was similar as that
measured in MPTC loaded with normal (1 mM) Pi, whereas Pi
uptake in response to Hyp serum, which resulted in no inhibition
following high Pi loading of MPTC for two days, was actually
higher (although not reaching statistical difference under these
conditions) than in MPTC treated with normal Pi loading (Fig. 6).
The presence of an intrinsic bone cell defect was evaluated by
the phenotypic expression of mouse primary osteoblast-like cell
(MPOC) cultures, and the effect of their conditioned-media (CM)
on Pi uptake by MPTC. MPOC showed features of normal
osteoblast-like cells, namely high ALPase (173.7 43.9 vs.
186.3 29.1 nMol/mg protein/30 mm, not significant between
normal and Hyp mouse) and osteocalcin secretion (23.5 3.0 vs.
41.4 5,1 ng/mg protein/48 hr, P < 0.025) for normal and Hyp
MPOC respectively. The twofold increase in OC production by
Hyp bone cells versus normal cells was expected since OC is a
hone specific protein synthesized exclusively by osteoblasts [32],
and recent data showed increased circulating OC levels in Hyp
versus normal mice [331. The effect of Hyp MPOC-CM on Na -Pi
cotransport by MPTC (no effect on Na-independent Pi uptake)
was compared with normal MPOC-CM, and media conditioned in
the absence of cells (Fig. 7). Pi uptake was significantly different
between the three groups (P < 0.005 by analysis of variance). It
was inhibited by 30.5 4.1% (P <0.05) between normal and Hyp
MPOC-CM (47.5 6.7% between Hyp and media alone), and Pi
uptake by MPTC pretreated with normal MPOC-CM was also
reduced as compared to media conditioned without cells (media
alone, 26.6 7.4%, P < 0.025). As for assays in the presence of
serum, normal and Hyp mouse bone cell-conditioned media failed
Fig. 6. Adaptation of phosphate uptake by MPTC in response to phosphate
loading in vitro. Cells were preincuhated in the presence of 0.4, 1 or 3 mrsi
phosphate (final concentration with serum) in culture media for 48 hours,
in the presence of bovine serum (•), normal () orHyp (El) serum (10%
final). Phosphate uptake (0.1 mM) was then performed as described in
Figure 2. Values are the mean SEM of 4 to 8 experiments. *p < 0.001,
**J) <0.01 vs. bovine serum. ap < 0.001 versus normal mouse serum; hp<
0.005 versus normal mouse serum, for respective individual phosphate
loading condition.
to elevate cAMP formation by MPTC under the present condi-
tions (Fig. 1). These treatments also failed to modify glucose and
a-aminobutyric acid transport by MPTC (not shown).
This effect of Hyp bone cell-conditioned media was not lost
upon multiple passages, whereas the effect of normal mouse bone
cell-conditioned media was reduced to 10% (not significantly
different from control with media alone) at the third passage.
However, Hyp MPOC-CM obtained from third passage cells still
inhibited Pi uptake by MPTC by 32 9.4% (P < 0.02 vs. media
alone or normal MPOC-CM). Finally, this effect of Hyp
MPOC-CM was not reproduced by CHO nor NCTC cell-condi-
tioned media (Fig. 8). Likewise, normal and Hyp Kupifer-like
cell-conditioned media failed to significantly inhibit Pi uptake by
MPTC (Fig. 8), although both showed a slight inhibition of about
10% as compared to media alone (no significant differences
between normal and Hyp Kupifer cells either).
Discussion
Our findings indicate that normal mouse serum may contain a
factor responsible for the inhibition of Pi uptake by primary renal
proximal cells, which becomes aberrant in Hyp mouse. The effect
observed between normal and Hyp mouse serum is comparable to
the inhibition by half of Pi uptake measured with isolated renal
brush border membrane vesicles [5, 6]. This inhibition is delayed,
and is not observed until after 12 hours of incubation. However,
after 24 hours of incubation, the inhibition reached its maximal
effect and remained unchanged. The time-dependent effect is
consistent with an inhibition of the synthesis of mRNA rather
than a direct effect at the post-transcriptional level [34]. The
0 12 24 36 48
Treatment time, hours
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Fig. 7. Effect of bone cell-conditioned media on Pi uptake by MPTC. Renal
cells were preincubated for 48 hours in the presence of conditioned media
(48 hr) of primary bone cell cultures from normal mice (Normal), Hyp
mice (Hyp) or media conditioned without cells (Media alone). Phosphate
uptake was then measured in the presence of 140 msi NaCI at 37°C for five
minutes as described in Figure 2. Values are the mean SEM of 7 to 10
experiments run in triplicate dishes per condition (P < 0.005 by analysis of
variance between the three groups). **p < 0.005, P < 0.025 versus media
alone.
mRNA for NaPi2 is reduced by 57 6% in Hyp mice, which leads
to a reduction by half of the Na-Pi cotransporter protein content
in isolated brush border membranes [341. The observation that
normal mouse serum may itself be inhibitory for Pi uptake in
MPTC as compared to fetal bovine serum (about 30%) is
surprising, nonetheless it may indicate a species specific difference
between bovine and mouse serum, not related to the presence of
a hypophosphatemic factor in normal mouse serum. However,
when MPTC were adapted in high Pi media, there were no more
differences between fetal bovine serum, normal and Hyp mouse
serum, strongly suggesting that the effect observed in low and
normal Pi media with normal mouse serum was genuine. Con-
versely, the possible dilution of medium Pi concentration using
10% FBS or normal mouse serum (or Hyp serum) is unlikely to
explain the inhibition of Pi uptake since Pi concentration in media
was adjusted in each case prior to conditioning of MPTC. Lastly,
these results could also suggest that the hypophosphatemic factor
is a normal regulator of phosphate reabsorption by the kidney,
and hence present normally in serum, but which becomes aberrant
in Hyp mouse.
This effect of Hyp mouse serum is specific for phosphate uptake
in renal cells. First, the effect was dose-dependent between 5 to
20% serum, and higher concentrations could not be tested at this
point due to the limited availability of serum. The relative
dose-dependent inhibition of Pi uptake observed with normal
mouse serum may further suggest the presence of this factor in
normal serum, which becomes aberrant in Hyp serum. This is also
supported by the demonstration that long incubations (36 and 48
hr) with normal mouse serum leads to Pi uptake inhibition in
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Fig. 8. Selective effect on Hyp mouse osteoblast-like cell conditioned-media
on Pi uptake by MPTC. Confluent MPTC cells were incubated for their last
48 hours of culture with conditioned media prepared in the absence of
cells (Media), or in the presence of CHO cells (CHO), mouse fibroblasts
(NCTC), normal Kupifer cells or Hyp Kupifer cells, normal or Hyp bone
cells. At the end of this treatment, MPTC were used to measure Pi uptake
as described in Figure 2 in the presence of 140 msi NaCI. Values are the
mean SEM of 3 to 8 experiments run in quadruplicate dishes per
condition. *p < 0.005; < 0.05 versus media alone. °P < 0.05 versus all
other cell-conditioned media tested.
MPTC. However, a significant difference is always observed
between normal and Hyp mouse serum regardless of dose or
duration, thus suggesting that this factor is more potent/abundant
in Hyp mouse serum.
Second, MPTC cells adapted to variable phosphate content in
their culture media for two days by altering their total phosphate
uptake, a situation well described in the literature both in vitro and
in vivo [35—37]. In addition, the decrease in phosphate uptake
following adaptation in high Pi media also prevented the inhibi-
tory effect of normal and Hyp mouse serum, regardless of the
actual decrease in Pi uptake due to Pi loading of these MPTC.
Indeed, the Hyp mutation and dietary phosphate restriction exert
their effects on the Vmax of the same high-affinity Pi uptake
system, albeit in opposite direction [61. The site of action of
parathyroid hormone (PTH), a major regulator of renal phos-
phate transport, is also the high affinity Pi uptake system [38]. The
adaptative response to a low Pi diet is attributed both to a rapid
response with the recruitment or activation of existing transport-
ers and a slower response involving new protein synthesis in rat
kidney in vivo [371 and in LLC-PK1 cells [35], whereas in opossum
kidney (OK) cells only a post-transcriptional event is involved
[361. LLC-PK1 and OK are model cell lines of proximal tubule
cells. It is now recognized that the NaPi2 cotransporter gene
product (mRNA and protein) is specifically affected by phosphate
manipulation. Therefore, down-regulation of NaPi2 expression in
response to high Pi media loading in MPTC would explain the loss
of response to Hyp mouse serum under these conditions.
Lastly, Hyp and normal mouse serum failed to modify either
sodium-dependent glucose or aminobutyric acid uptake, yet in-
hibited Pi uptake, indicating that a modification of the sodium-
gradient driving force is probably not involved in Pi uptake
inhibition. Since neither normal nor Hyp mouse serum caused any
effect on these transports under similar treatment conditions as
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for phosphate uptake preparations, this also strongly suggests that
the inhibition of phosphate uptake by normal mouse serum was
not due to an intrinsic modification of the culture conditions
[ionic composition, media pH (initially adjusted with 15 mM
HEPES) and metabolite concentration of the culture media], nor
a difference between fetal bovine serum and mouse serum that
would have induced a non-specific inhibition.
Most importantly, our findings are the first to indicate that this
hypophosphatemic factor is produced by Hyp osteoblast-like cells,
and moreover this factor may also be produced by normal mouse
osteoblast-like cells, since conditioned media from primary nor-
mal mouse bone cells also resulted in a selective, yet small,
inhibition of phosphate uptake by MPTC. The hypothesis that this
factor is intrinsic to osteoblast-like cells is supported by the
absence of inhibition of Pi uptake by MPTC treated with condi-
tioned media from mouse fibroblasts (NCTC cells), CHO cells,
and normal and Hyp Kupffer cells. The absence of effect of these
cell-conditioned media on Pi uptake by MPTC also indicate that
unspecific inhibition of Pi uptake by MPTC due to cell metabo-
lism, leading to variations in media pH, ionic and metabolites
composition, is very unlikely as already pointed out for the effect
of serum. However, the effect of normal bone cells is lost upon
multiple passages, whereas this was not the case for Hyp mouse
bone cells.
This further indicates that a factor (hormone, cytokine?) elab-
orated and/or modified (in the culture media containing 10%
FBS) by osteoblasts may reach the circulation and affect renal Pi
reabsorption. The effect of this circulating factor is specific for
Na-Pi cotransport, as glucose, amino acid uptake and sodium-
independent uptake were not affected by serum. Furthermore, our
results indicate that under identical culture conditions Hyp
MPOC produce more of this factor than normal MPOC. These
results may not be attributed to PTH nor PTH related-peptide-
dependent cAMP production by MPTC in response to MPOC-
CM, since normal and Hyp MPOC-CM as well as serums from
both normal and Hyp mouse failed to stimulate cAMP production
by MPTC. Whether this factor acts directly or through the
modulation of yet another effector is presently unknown. It could
be either a primary factor, produced and released by bone cells, or
else it could be a secondary factor modified in vitro by Hyp bone
cells carrying the primary alteration. This last hypothesis would
agree with the recent findings of Francis et al [14] of the PEX
gene, an homologue of endopeptidases, localized on the X-chro-
mosome, and possibly involved in phosphate homeostasis.
Cai et al [22] reported that conditioned-media from cultured
sclerosing hemangioma cells obtained from a patient with onco-
genie osteomalacia inhibited Pi transport in a renal model cell line
(OK cells). A similar result was recently obtained by another
group using conditioned-media from cultured tumor cells isolated
from the infratemporal fossa of a patient with hypophosphatemia,
osteomalacia, elevated alkaline phosphatase and low 1,25-dihy-
droxyvitamin D3 [23]. Whether this factor(s) is related to the
factor present in Hyp mouse serum (and possibly XLH) remains
to be determined. Lastly, the demonstration by Nesbitt et al [39]
that immortalized cell cultures from the renal proximal tubule of
normal and Hyp mice failed to show any significant differences in
phosphate uptake kinetics also strongly argues that the Hyp gene
locus product is an extrarenal factor, such as the one we partly
characterized here.
In conclusion, Hyp mouse serum inhibits phosphate transport in
primary cultures of mouse renal tubular cells, and this effect is
specific for Pi uptake. A similar effect is observed with condi-
tioned medium from Hyp mouse osteoblasts, strongly suggesting a
possible origin for this hypophosphatemic factor, since it could
not be reproduced by mouse fibroblasts (NCTC cells), CHO cells
nor normal and Hyp mouse Kupffer cells.
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